Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about RHHBY

Recent news which mentions RHHBY

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Are Eli Lilly and Novo Nordisk Too Expensive For You? Here Are 4 Other Potential Weight Loss Stocks You May Want to Consider Right Now.
Tickers ALT LLY NVO PFE
Tags NVO LLY Recent Press Releases
From Motley Fool
Weight Loss Drug Stocks Just Took a Hit. Should You Buy the Stock That Caused It?
Tickers LLY NVO RHHBY
Tags LLY NVO Recent Press Releases
From Motley Fool
Novo Nordisk's Stock Dips In Pre-Market Despite Winning UK's Approval Of Weight Loss Drug: What's Going On
Tickers LLY NEWS NVO PFE
Tags Biotech Benzinga PFE
From Benzinga
Look Out, Eli Lilly and Novo Nordisk: Could Roche Be the Obesity Drug Stock to Really Watch?
Tickers LLY NVO RHHBY
Tags Recent Press Releases Market News NVO
From Motley Fool
Oral Weight Loss Drugs Vs. Injections - Pills Are Promising Yet Challenging Frontier
Tickers LLY NEWS NVO PFE
Tags RHHBY Market News News
From Benzinga
This Big Pharma Could Become a Leading Weight-Loss Stock. Should You Buy It?
Tickers RHHBY
Tags RHHBY Recent Press Releases Market News
From Motley Fool
Better Dark Horse Weight Loss Drug Stock: Pfizer vs. Roche
Tickers PFE RHHBY
Tags Recent Press Releases Market News RHHBY
From Motley Fool
EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
Tickers AMGN AZN HRTS LLY
Tags NVO AMGN Top Stories
From Benzinga
VIX Stages Double-Digit Spike As Risk Off Takes Over; Chipmakers Fail To Rebound, Weight Loss Giants Eli Lilly, Novo Tumble: What's Driving Markets Thursday?
Tickers AA ABT ALK BX
Tags DPZ VIRT NVS
From Benzinga
Why Roche Stock Just Popped, but Eli Lilly and Novo Nordisk Dropped
Tickers LLY NVO RHHBY
Tags Recent Press Releases Market News NVO
From Motley Fool
Pfizer And Roche Advance On Their Weight Loss Drug Journeys
Tickers LLY NEWS NVO PFE
Tags RHHBY General Market News
From Benzinga
Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics?
Tickers GPCR LLY NEWS NVO
Tags Benzinga weight loss drugs Stories That Matter
From Benzinga
Roche Highlights Encouraging Data From Newly-Acquired Second Weight Loss Drug Candidate In Early-Stage Study
Tickers NEWS RHHBY
Tags Weight Loss Drug Briefs Benzinga
From Benzinga
3 Small-Cap Stocks With Explosive 2X Growth Potential
Tickers AMGN BAYRY CHPT EXAI
Tags AMGN NYSE:CHPT,NASDAQ:EXAI,NASDAQ:VRDN,OTCMKTS:RHHBY,OTCMKTS:BAYRY,NASDAQ:AMGN VRDN
From InvestorPlace
Roche's New Immunotherapy Fails To Show Benefit Over Merck's Blockbuster Keytruda In Lung Cancer Patients
Tickers MRK NEWS RHHBY
Tags General Biotech Stories That Matter
From Benzinga
AbbVie/Genmab's Epkinly FDA Approval Is A Positive Step, Analyst Says Additional Expansion Opportunities Underway
Tickers ABBV BNTX GMAB JNJ
Tags Market News BNTX Analyst Color
From Benzinga
Supreme Court Backs Pharmaceutical Giants in Iraq Terrorism Funding Case
Tickers AZN GEHC JNJ NEWS
Tags Market News AZN RHHBY
From Benzinga
Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments
Tickers AMGN AZN BMY GILD
Tags General Media Briefs
From Benzinga
Sarepta Therapeutics (SRPT) Stock Surges 30% on Giant FDA Boost
Tickers RHHBY SRPT
Tags RHHBY NASDAQ:SRPT,OTCMKTS:RHHBY SRPT
From InvestorPlace
FDA Approves Expanded Use For Sarepta's Rare Muscular Dystrophy Gene Therapy
Tickers NEWS PFE RGNX RHHBY
Tags Movers Biotech Benzinga
From Benzinga
Goldman Sachs Optimistic About Regenxbio's Gene Therapy Pipeline, Sees Over 160% Upside
Tickers ABBV FDMT NEWS REGN
Tags Price Target Expert Ideas Briefs
From Benzinga
Italy Probes European Pharma Giants Novartis, Roche Over Eye Drug Competition Allegations
Tickers NEWS NVS RHHBY
Tags Market News NVS RHHBY
From Benzinga
2 Cathie Wood Biotech Stocks That Could Be Worth the Risk
Tickers ARKG ARKK DNA RHHBY
Tags Market News RHHBY ARKK
From Motley Fool
If You'd Invested $100 in Viking Therapeutics Stock 2 Years Ago, Here's How Much You'd Have Today
Tickers GS RHHBY VKTX
Tags RHHBY VKTX GS
From Motley Fool
Biden Administration Urges Supreme Court Review in Terrorism Funding Lawsuit Against Pharma Companies
Tickers AZN GEHC JNJ PFE
Tags Biotech Stories That Matter Benzinga
From Benzinga
This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan
Tickers BHVN GPCR LLY NEWS
Tags obesity Benzinga Biotech
From Benzinga
Roche To Ride Booming Obesity Treatment Market With Newly-Acquired Drug Candidate
Tickers NEWS RHHBY
Tags Briefs Stories That Matter Benzinga
From Benzinga
Can Ocugen Stock Keep Churning Higher?
Tickers OCGN RHHBY VHT
Tags Recent Press Releases Market News OCGN
From Motley Fool
Why Is Penny Stock HOOKIPA Pharma Trading Higher On Wednesday?
Tickers GILD HOOK NEWS RHHBY
Tags why it's moving RHHBY GILD
From Benzinga
2 Small-Cap Growth Stocks With Room To Run
Tickers ACHR OCUL REGN RHHBY
Tags RHHBY REGN OCUL
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.